Novartis to divest blood transfusion diagnostics unit to Grifols, may sell animal health and OTC units
09:34 AM | November 11, 2013 | Natasha Alperowicz
Pharmaceuticals major Novartis (Basel) today announced a definitive agreement to divest its blood transfusion diagnostics unit, headquartered in Emeryville, CA, to Grifols (Barcelona) for $1.675...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.